Cargando…
Efficacy and safety of the recombinant human growth hormone in short children born small for gestational age: A randomized, multicentre, comparative phase III trial
OBJECTIVE: Growth hormone (GH) treatment is known to be effective in increasing stature in children with a short stature born small for gestational age (SGA). This multicentre, randomized, open-label, comparative, phase III study aimed to evaluate the efficacy and safety of Growtropin-II (recombinan...
Autores principales: | Kim, Su Jin, Kim, Min-Sun, Cho, Sung Yoon, Suh, Byung-Kyu, Ko, Cheol Woo, Lee, Kee-Hyoung, Yoo, Han-Wook, Shin, Choong Ho, Hwang, Jin Soon, Kim, Ho-Seong, Chung, Woo Yeong, Kim, Chan Jong, Han, Heon-Seok, Jin, Dong-Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322493/ https://www.ncbi.nlm.nih.gov/pubmed/34397702 http://dx.doi.org/10.1097/MD.0000000000026711 |
Ejemplares similares
-
SUN-259 Recombinant Growth Hormone Therapy for Children with Turner Syndrome in Korea: A Phase III Randomized Trial
por: Kim, Jinsup, et al.
Publicado: (2019) -
Recombinant growth hormone therapy in children with Turner Syndrome in Korea: a phase III Randomized Trial
por: Kim, Jinsup, et al.
Publicado: (2021) -
Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort
por: Kim, Hae Jin, et al.
Publicado: (2018) -
Risk factors of severe hypoglycemia requiring medical assistance and neurological sequelae in patients with diabetes: A case–control study
por: Jeon, Ja Young, et al.
Publicado: (2016) -
Diabetes self-assessment score and the development of diabetes: A 10-year prospective study
por: Kim, Gyuri, et al.
Publicado: (2017)